To summarize the experience of laparoscopic pancreaticotailectomy, and investigate the feasibility and clinical value of the therapy for pancreatic tail-mass.

Clinical data of 32 patients who underwent pancreaticotailectomy in the Department Liver and Gallbladder Surgery of Cangzhou People′s Hospital from Jan. 2016 to Dec. 2019 were retrospectively analyzed.Among them, there were 12 males and 20 females, aged 13-75 years, and the average age was (41.3±3.7)years. During the operation, whether to retain the spleen or not was determined according to the features of the tumor, the relationship between the tumor and splenic vessels, and the degree of spleen injury.

Except for one patient who underwent laparotomy due to tumor invasion of transverse colon, the other 31 patients underwent laparoscopic resection.Spleen was retained in 12 cases (8 by Kimura method and 4 by Warshaw method) and 20 by combined splenectomy.The mean operation time was (252±75) min, and the mean intraoperative blood loss was (162±51) ml.Postoperative hospital stay was (11.6±3.2) days.Postoperative pathology: solid pseudopapilloma (10 cases), serous cystadenoma (6 cases), mucinous cystadenoma (4 cases), neuroendocrine tumor (4 cases), pancreatic adenocarcinoma (3 cases), inductal papillary myxoma (3 cases), pancreatic pseudocyst (1 case), and pancreatic tail injury (1 case). Postoperative pancreatic leakage occurred in 10 cases, and they were cured and discharged after adequate drainage and anti-infection treatment.There were 1 case of chylous leakage, 1 case of peritoneal hemorrhage (recovered after conservative treatment with somatostatin and hemostatic agents), and 5 cases of new postoperative diabetes.

Laparoscopic pancreaticotailectomy is safe and effective in the treatment of pancreatic body and tail tumor. Surgeons with extensive experience in laparoscopic surgery can perform them.